Ranibizumab for neovascular age-related macular degeneration
Funding Not reported
Source
Rosenfeld P. et al.. Ranibizumab for neovascular age-related macular degeneration. The New England journal of medicine. Sunday, January 1, 2006.
doi:10.1056/nejmoa054481Read original ↗
doi:10.1056/nejmoa054481Read original ↗
Generated, then checked against the source · how this brief was built →
Sign in to rate and bookmark articles
Automated evidence summary, checked against the source. Not medical advice. Verify with the original publication.